Skip to main content



) --




) hit a new 52-week high Thursday as it is currently trading at $17.79, above its previous 52-week high of $17.73 with 145,751 shares traded as of 10:47 a.m. ET. Average volume has been 311,000 shares over the past 30 days.

Medicines has a market cap of $927.4 million and is part of the

health care

sector and



The Medicines Company operates as a global pharmaceutical company with a focus on advancing the treatment of critical care patients. The company markets Angiomax for use in patients undergoing coronary angioplasty; and Cleviprex, an injectable emulsion for the reduction of blood pressure.

  • Practice your MDCO trading strategies and win cash in our stock game.

TheStreet Ratings rates Medicines as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full

Medicines Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center